Assessment of the efficacy of using intraumbilical vein injection of oxytocin after delivery of newborn in reducing postpartum hemorrhage
Not Applicable
- Conditions
- postpartum hemorrhage.Third-stage haemorrhage
- Registration Number
- IRCT201204179491N1
- Lead Sponsor
- Qazvin University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 200
Inclusion Criteria
Inclusion criteria : vaginal delivery;gestational age 37-42 weeks;singleton pregnancy;live fetus;cephalic presentation;neonatal birth weight 2500-4500 gram;parity 1-3.
exclusion criteria : blood pressure140/90 or greater;placenta previa;placental abruption;abnormal placentation;instrumental delivery;history of postpartum hemorrhage;
history of curretage or cesarean delivery or any uterine scar;coagulopathy;hydramnios;known uterine anomaly;large episiotomy or vaginal lacerations those were repaired in operation room.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Assessment of the efficacy of using intraumbilical vein injection of oxytocin in active management of the third stage of labor in reducing postpartum hemorrhage. Timepoint: 24 hours after intervention. Method of measurement: hemoglobin level(gr/dl).
- Secondary Outcome Measures
Name Time Method Incidence of retained placenta need for manual removal of placenta in each group. Timepoint: in third stage of labor. Method of measurement: percentage.;Incidence of using additional uterotonics in each group. Timepoint: during the third stage of labor and 24 hours later. Method of measurement: percentage.;Incidence of falling hemoglobin levels in each group. Timepoint: during the third stage of labor and 24 hours later. Method of measurement: gr/dl.;Duration of the third stage of labor in each group. Timepoint: during the third stage of labor. Method of measurement: minutes and seconds.;Incidence of transfusion after delivery in each group. Timepoint: during 24 hours after delivery. Method of measurement: percentage.